AI Article Synopsis

  • Research shows that spatial attention and visual working memory are closely connected, but they are not the same thing.
  • EEG data from two studies reveal that while attention can track where and how much space is monitored, this doesn’t directly indicate how many items are held in memory.
  • The findings suggest that spatial attention and working memory function independently, with attention aiding but not determining what we remember.

Article Abstract

Past work reveals a tight relationship between spatial attention and storage in visual working memory. But is spatially attending an item tantamount to working memory encoding? Here, we tracked electroencephalography (EEG) signatures of spatial attention and working memory encoding while independently manipulating the number of memory items and the spatial extent of attention in two studies of adults ( = 39; = 33). Neural measures of spatial attention tracked the position and size of the attended area independent of the number of individuated items encoded into working memory. At the same time, multivariate decoding of the number of items stored in working memory was insensitive to variations in the breadth and position of spatial attention. Finally, representational similarity analyses provided converging evidence for a pure load signal that is insensitive to the spatial extent of the stored items. Thus, although spatial attention is a persistent partner of visual working memory, it is functionally dissociable from the selection and maintenance of individuated representations in working memory.

Download full-text PDF

Source
http://dx.doi.org/10.1177/09567976241263002DOI Listing

Publication Analysis

Top Keywords

working memory
32
spatial attention
24
memory
9
spatial
8
working
8
visual working
8
items spatial
8
spatial extent
8
attention
7
electroencephalogram decoding
4

Similar Publications

Background: Dysregulated GABA/somatostatin (SST) signaling has been implicated in psychiatric and neurodegenerative disorders. The inhibition of excitatory neurons by SST+ interneurons, particularly through α5-containing GABAA receptors (α5-GABAAR), plays a crucial role in mitigating cognitive functions. Previous research demonstrated that an α5-positive allosteric modulator (α5-PAM) mitigates working memory deficits and reverses neuronal atrophy in aged mice.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Actinogen Medical, Sydney, Australia.

Background: Selecting the optimal dose for clinical development is especially problematic for drugs directed at CNS-specific targets. For drugs with a novel mechanism of action, these problems are often greater. We describe Xanamem's clinical pharmacology, including the approach to dose selection and proof-of-concept studies.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) is a neurodegenerative disorder without a cure. Targeting this multifactorial disease by repurposing FDA approved drugs serves as a faster mode of treatment due to its pre-established human safety. We tested terazosin (TZ), an a-1 adrenergic receptor (AR) antagonist and phosphoglycerate kinase-1 (PGK1) activator as having potential to treat AD.

View Article and Find Full Text PDF

Background: Acetylcholine, a neurotransmitter critical for cognitive functions, including attention, memory, and sociability, is essential for maintaining synaptic integrity. Deficits in acetylcholine levels are linked to cognitive impairments. Heterozygous VAChT KD (VAChT KDHET) mice, characterized by reduced vesicular acetylcholine transporter protein production, exhibit cognitive impairments due to diminished acetylcholine release.

View Article and Find Full Text PDF

Background: The increased incidence of Alzheimer's disease (AD) rate represent an unmet medical need and thus critical for the development of novel molecular therapeutics. Recent work focusing on patients with apoE4 alleles has highlighted the association of brain cholesterol dysregulation with elevated pathological burden and neurodegeneration. These studies have highlighted the importance of the nuclear receptor Liver X receptor (LXR) for developing AD therapies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!